edelfosine has been researched along with Diffuse Large B-Cell Lymphoma in 2 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diomede, L | 1 |
| Damia, G | 1 |
| D'Incalci, M | 1 |
| Imperatori, L | 1 |
| Algeri, M | 1 |
| Modest, EJ | 1 |
| Salmona, M | 1 |
| Pushkareva, MY | 1 |
| Wannberg, SL | 1 |
| Janoff, AS | 1 |
| Mayhew, E | 1 |
2 other studies available for edelfosine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
In vivo anti-tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition.
Topics: Animals; Antineoplastic Agents; Cell Membrane; Cholesterol; Drug Combinations; Female; Glycerides; L | 1994 |
Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Topics: Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Cell Differentiation; | 2000 |